Chair’s Welcome

A welcome from Darren Mott, the Non-Executive Chair of Octavian

Welcome to Octavian

Engaging with our stakeholders is a key priority. Whether you are an investor, a potential partner, a researcher, or simply interested in our work, we want to ensure you have a clear understanding of our company, our mission, and our drug development programmes.

We are committed to pioneering safe and effective prescription medicines targeting the endocannabinoid system, with a particular focus on chronic pain. Through innovation, collaboration, and scientific rigour, we aim to address unmet medical needs and deliver real impact.

We hope this platform provides valuable insight into our organisation, strategy, and future plans.

Lord Darren Mott, OBE, Non-Executive Chair